(Total Views: 343)
Posted On: 01/05/2020 10:48:34 AM
Post# of 155128
A bit over-optimistic imo and partly incoherent. On the one hand, I don't expect NASH licensing deal in March. On the other hand, if so, SP would go up to the sky.
But honestly speaking, I suspect it's still a long(er) way to cancer and NASH revenues and even HIV mono approval is not realistic before H2/2021 imo.
And our poor cash situation will be problematic too, at least to some extent when it comes to how much do we got from the cake (trding hinted at that).
That's why I'm desperately waiting for BLA Combo. That would make me 100% calm, giving me the opportunity to stop checking SP every hour and just knowing that the future will be bright.
But honestly speaking, I suspect it's still a long(er) way to cancer and NASH revenues and even HIV mono approval is not realistic before H2/2021 imo.
And our poor cash situation will be problematic too, at least to some extent when it comes to how much do we got from the cake (trding hinted at that).
That's why I'm desperately waiting for BLA Combo. That would make me 100% calm, giving me the opportunity to stop checking SP every hour and just knowing that the future will be bright.
(1)
(0)
